Geron | GERN - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Amgen USD 24.96B 534M 2026-03
Bio Techne USD 153.28M 12.85M 2026-03
Cassava Sciences USD 40.11M 3.72M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Esperion Therapeutics USD 300.36M 451K 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Genmab DKK 1.43B 686M 2025-12
Geron USD 73.57M 40.25M 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Incyte USD 1.49B 25.52M 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03